NERVOSAVE Healthy nerves.
Brighter lives.
Protecting, restoring and enhancing nerve function through a targeted, locally delivered gene therapy platform — for people and companion animals.
Local delivery. Long-term ambition.One platform.
Multiple possibilities.
From inherited neuropathies to chronic pain, hearing health and veterinary medicine, our research programs explore the potential of local nerve-targeted delivery.
Inherited peripheral neuropathies
Addressing the biology of Charcot–Marie–Tooth disease.
Explore →
Neuropathic pain & intensive users
Exploring local approaches for difficult-to-treat nerve pain.
Explore →
Hearing & ageing
Research into preserving auditory nerve function.
Explore →
Companion animal pain
A potential durable approach to severe canine neuropathic pain.
Explore →
Target the nerve.
Think long term.
Our investigational platform uses local perineural administration of AAV vectors to target cells associated with peripheral nerves. The approach is designed to limit systemic exposure and support sustained local therapeutic activity.
Built in Europe.
Accelerated in China.
Scaling internationally.
Combining European innovation and intellectual property, clinical development opportunities in China, and international partnerships to advance new options for nerve health.
Help shape the next generation of nerve care.
We welcome clinical, scientific, veterinary and investment partners interested in developing this platform.
Get in touch ↗